| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Management > How to Control a Project Without Formal Project Management |
|
Digg It - How to Control a Project Without Formal Project Management
You will probably have experienced this. You are the sponsor of a small project. It is not really a heavy project but t According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product he activities are not part of the daily routine. Also there is some risk involved, basically it is a project without a ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in eal plan. There is however a final date set. And then, the activities start. You have done your part of the project in lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. the beginning which was the basis for others to complete the work. In fact this could be anything where some expertise here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe s required on which you depend on others. You ask how things are going, and as always, in the beginning “everything is d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro going fine.” But how do you know this? In the case where there would be a project and a real plan, you would focus on a ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc tivities and dates which are due some moment in time. But now these are not really defined. There is no real control. easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi he end of the story is that when the deadline is near, the work is not finished. And then what? Do you make a plan afte nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically all? You ask what is going on... You would like to know where the problem is? Project management rule # one; if there and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ is no project there is no control and you depend on the circumstances. A normal reaction of an organization is to "inst ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ll" a (formal) project management approach. There are many cultural differences amongst companies and countries in this ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a area of project management. They differ in the approach they choose. But equally important in whatever approach is the dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod communication around the project. Ideally you would like to add as little overhead to you project, up to the point tha cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin you are still able to manage it. The benefit of a formal project planning is that risks are controlled, but the questi tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen n is – at what price? For smaller projects you should focus on the risk areas. But you do not know them. So you should t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel sk.
Project management is much to do about communication. About exchanging information and building up knowledge. If ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ou are a sponsor, ask for the risks that are involved. You do not want and have to know the details, but you want some y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products roof (of the concept).
Make sure you have those risks outlined over time. This give both parties some moments in time . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de o focus on. And you may be relieved knowing that when the risks are controlled the project is safe. Project management elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip is about communication and sharing information. In your case as a sponsor you shouldn't stop asking... © 2006 Hans Boo tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Fifteen Areas Reviewed in a Due Diligence Study
|